000 01355 a2200397 4500
005 20250511175607.0
264 0 _c19930629
008 199306s 0 0 eng d
022 _a0197-0186
024 7 _a10.1016/0197-0186(92)90086-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaysinger, D
245 0 0 _aGrafting of genetically modified cells: effects of acetylcholine release in vivo.
_h[electronic resource]
260 _bNeurochemistry international
_cDec 1992
300 _a543-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcetylcholine
_xmetabolism
650 0 4 _aAcetylcholinesterase
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aCerebral Cortex
_xmetabolism
650 0 4 _aDialysis
650 0 4 _aFibroblasts
_xmetabolism
650 0 4 _aGenetic Engineering
650 0 4 _aMale
650 0 4 _aNeostigmine
_xpharmacology
650 0 4 _aNerve Growth Factors
_xmetabolism
650 0 4 _aPia Mater
_xblood supply
650 0 4 _aPotassium Chloride
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Wistar
700 1 _aPiccardo, P
700 1 _aGoiny, M
700 1 _aCuello, A C
773 0 _tNeurochemistry international
_gvol. 21
_gno. 4
_gp. 543-8
856 4 0 _uhttps://doi.org/10.1016/0197-0186(92)90086-7
_zAvailable from publisher's website
999 _c1310262
_d1310262